Eduardo Vélez S.

De 🇵🇪 | 📌Barcelona

[OpenAI @OpenAI]

This is GPT-6 Astra.

Anything you can do on a computer, Astra can do for you. Fast.

[Arjun (Raj) Manrai @arjunmanrai]

🧵1/ Our new study on AI and physician reasoning just came out in @ScienceMagazine. As co-senior author, I'm excited about our findings, and I do think AI will reshape medicine. But after seeing some of the discussions, I'm also worried about how our findings may be misinterpreted.

[Satya Nadella @satyanadella]

A great example of what's possible when someone connects their passion with their purpose to make a real difference.

DxGPT, a rare disease diagnostic tool, is now live, showing how AI can be applied to help truly improve lives.

[3Cat Corporatiu @3CatCorporatiu]

🫁 Arrenca “A ple pulmó” #LaMarató3Cat per les malalties respiratòries

❌ A Catalunya hi ha 2.000.000 de persones afectades

🖥️ Des d’ara i fins al 15 de desembre #3Cat tindrà una programació especial

❤️ L’objectiu de #LaMarató3Cat és captar fons per a la recerca i sensibilitzar la població

[NEJM @NEJM]

Presented at #ATS2023: In the BOREAS trial, dupilumab resulted in a lower annualized rate of exacerbations than placebo among patients with COPD and an elevated blood eosinophil count. Full trial results: https://t.co/9IWZr3YqsN

[Eduardo Vélez S. @eduvelez4]

Empezó #55CongresoSEPAR #Pamplona

[Deji Adegunsoye, MD, PhD @drdayjee]

🔥Finally out online: the latest multisocietal guidance defining progression in fibrotic lung disease🫁 has arrived!

These long-awaited guidelines help better clarify disease definition and guide treatment
https://t.co/LVuoVdZRj2

What does this mean? Hang on to your hats! 🧵1/n

[Eduardo Vélez S. @eduvelez4]

The evaluation of the response to treatment must be dynamic and include physiological and gasometric parameters (such as the ROX index)

[Eduardo Vélez S. @eduvelez4]

Summary of recommendations for the use of HFNC @EuroRespSoc

[Eduardo Vélez S. @eduvelez4]

It is not prohibited in hypercapnic respiratory failure (the evidence to recommend NIV over HFNC is still low). In patients with poor tolerance to NIV, HFNC can be tried

[Eduardo Vélez S. @eduvelez4]

@FotoRuanoPro a ver si hay suerte 🍀 😄

[Foto Ruano @FotoRuanoPro]

¡SORTEAMOS LA NUEVA #SonyAlpha7IV

¿Quieres participar? Sigue estos pasos:
Inscríbete en el siguiente link
https://t.co/MWmp09WC0I

Síguenos en nuestro perfil de Twitter
Síguenos en nuestro perfil de Facebook o Instagram o YouTube
RT y etiquétanos.

#FotoRuano

[Eduardo Vélez S. @eduvelez4]

Felicidades @lourdesalazarh !! 🎉🙌🏼

[SEAP-IAP @SEAP_IAP]

¡Ya tenemos los ganadores del #5x5!

🥇Alvaro Lopez Janeiro
🥈Sarah Acosta Cajo
🥉Lourdes Salazar Huayna

Muchas felicidades 🎉🏆

[Eduardo Vélez S. @eduvelez4]

@ReniecPeru El programa sigue funcionando? Se puede usar desde el extranjero? Hay otra forma de verificar quien esta revisando mis datos personales? Gracias!

[Eduardo Vélez S. @eduvelez4]

Felicidades @lourdesalazarh !! 🙌 Gran equipo el de Anatomía Patológica del VH @vallhebronpath

[VallHebronPath @vallhebronpath]

Enhorabuena a nuestra queridísima residente @lourdesalazarh y a todo el equipo de #cytopath y #ENTpath de @vallhebron por este fantástico reconocimiento

[Neumología Vall d´Hebron @NeumologiaHVH]

Puertas abiertas online - Neumologia Vall Hebron. Martes 11 de mayo a las 17:30! 🗓

[Eduardo Vélez S. @eduvelez4]

Hot topics en embolia pulmonar @SeparRespira 1ra Reunión virtual Áreas SEPAR 2021

[Iñigo Ojanguren @InigoOjanguren]

Pretty interesting! Confirming our experience with these patients.
Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment | Annals of the American Thoracic Society https://t.co/tUD9ILbFgK

[Eric Topol @EricTopol]

A small randomized trial (N=146) of inhaled steroids for mild covid showed a significant reduction of clinical deterioration [1° endpoint (10)14% vs (1)1%]
https://t.co/Ze5GZLRpKt @LancetRespirMed

[Eduardo Vélez S. @eduvelez4]

Guardia muy variada y productiva la de hoy!! 💪